These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 18849167
1. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells. Sawada GA, Raub TJ, William Higgins J, Brennan NK, Moore TM, Tombline G, Detty MR. Bioorg Med Chem; 2008 Nov 15; 16(22):9745-56. PubMed ID: 18849167 [Abstract] [Full Text] [Related]
2. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW. Drug Metab Dispos; 2006 May 15; 34(5):786-92. PubMed ID: 16455806 [Abstract] [Full Text] [Related]
3. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME, Podila L, Ely D, Almeida I. Drug Metab Dispos; 2005 Nov 15; 33(11):1679-87. PubMed ID: 16093365 [Abstract] [Full Text] [Related]
4. ATP occlusion by P-glycoprotein as a surrogate measure for drug coupling. Tombline G, Holt JJ, Gannon MK, Donnelly DJ, Wetzel B, Sawada GA, Raub TJ, Detty MR. Biochemistry; 2008 Mar 11; 47(10):3294-307. PubMed ID: 18275155 [Abstract] [Full Text] [Related]
5. Rational use of in vitro P-glycoprotein assays in drug discovery. Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, Serabjit-Singh CS. J Pharmacol Exp Ther; 2001 Nov 11; 299(2):620-8. PubMed ID: 11602674 [Abstract] [Full Text] [Related]
6. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane. Regev R, Katzir H, Yeheskely-Hayon D, Eytan GD. FEBS J; 2007 Dec 11; 274(23):6204-14. PubMed ID: 17986257 [Abstract] [Full Text] [Related]
7. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells. Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF. Biochem Pharmacol; 2006 Sep 28; 72(7):824-37. PubMed ID: 16889754 [Abstract] [Full Text] [Related]
8. A cationic chalcogenoxanthylium photosensitizer effective in vitro in chemosensitive and multidrug-resistant cells. Holt JJ, Gannon MK, Tombline G, McCarty TA, Page PM, Bright FV, Detty MR. Bioorg Med Chem; 2006 Dec 15; 14(24):8635-43. PubMed ID: 16945541 [Abstract] [Full Text] [Related]
9. Selective modulation of P-glycoprotein-mediated drug resistance. Bebawy M, Morris MB, Roufogalis BD. Br J Cancer; 2001 Dec 14; 85(12):1998-2003. PubMed ID: 11747345 [Abstract] [Full Text] [Related]
11. Analogues of tetramethylrosamine as transport molecules for and inhibitors of P-glycoprotein-mediated multidrug resistance. Gibson SL, Hilf R, Donnelly DJ, Detty MR. Bioorg Med Chem; 2004 Sep 01; 12(17):4625-31. PubMed ID: 15358289 [Abstract] [Full Text] [Related]
12. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin. Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R. Cancer Chemother Pharmacol; 2005 Aug 01; 56(2):173-81. PubMed ID: 15824923 [Abstract] [Full Text] [Related]
13. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Evers R, Kool M, Smith AJ, van Deemter L, de Haas M, Borst P. Br J Cancer; 2000 Aug 01; 83(3):366-74. PubMed ID: 10917553 [Abstract] [Full Text] [Related]